Floatz logo

Therapeutic Asset Ratings

6,299 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
qh101
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1/2CC (45)
ql2107
Gastric Cancer
Qilu Pharmaceutical Co., Ltd.P1/2CC (45)
qlc1101
Neoplasm
Qilu Pharmaceutical Co., Ltd.P1/2CC (45)
qlp2117
Cancer
Qilu Pharmaceutical Co., Ltd.P1/2CC (45)
qls5132
Cancer
Qilu Pharmaceutical Co., Ltd.P1/2CC (45)
qls5132
Gastric Cancer
Qilu Pharmaceutical Co., Ltd.P1/2CC (45)
Rabbit Anti-Thymocyte Globulin
Childhood Acute Myeloid Leukemia
Washington University School of MedicineP1/2CC (45)
rc1012
Acute Myeloid Leukemia
Guangdong Ruishun Biotech Co., LtdP1/2CC (45)
rd14-01
Neoplasm
920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaP1/2CC (45)
Regn7945
Plasma Cell Myeloma
Regeneron PharmaceuticalsP1/2CC (45)
Regorafenib
Cervical Cancer
Neonc Technologies, Inc.P1/2CC (45)
Regorafenib
Esophageal Cancer
Neonc Technologies, Inc.P1/2CC (45)
Regorafenib
Squamous Cell Carcinoma
Neonc Technologies, Inc.P1/2CC (45)
Resp302
Bronchiectasis
Thirty Respiratory LimitedP1/2CC (45)
Resp303
Bronchiectasis
Thirty Respiratory LimitedP1/2CC (45)
Rezatapopt
Cancer
PMV Pharmaceuticals, IncP1/2CC (45)
Ribociclib
Invasive Breast Carcinoma
Jonsson Comprehensive Cancer CenterP1/2CC (45)
Rimiducid
Acute Lymphoblastic Leukemia
Fred Hutchinson Cancer CenterP1/2CC (45)
Rimiducid
Cortical Thymoma
Beijing BiotechP1/2CC (45)
Rintatolimod
Malignant Pancreatic Neoplasm
Joachim Aerts, MD PhDP1/2CC (45)
Rmc-9805
Colorectal Cancer
Revolution Medicines, Inc.P1/2CC (45)
Rmc-9805
Digestive System Cancer
Revolution Medicines, Inc.P1/2CC (45)
Rmc-9805
Malignant Pancreatic Neoplasm
Tango Therapeutics, Inc.P1/2CC (45)
Rmc-9805
Thoracic Cancer
Tango Therapeutics, Inc.P1/2CC (45)
RNK08954
Pancreatic Ductal Adenocarcinoma
InxMed (Shanghai) Co., Ltd.P1/2CC (45)
Showing 3776 to 3800 of 6,299 assets
PreviousPage 152 of 252Next